Kiniksa Pharmaceuticals Ltd (KNSA) Price Prediction & ForecastKNSAKiniksa Pharmaceuticals Ltd

Alphio's KNSA stock price prediction model matches the current Kiniksa Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $79.62 (+1.97%). The 1-week path is $79.27 (+1.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiniksa Pharmaceuticals appears to be a good buy right now due to its recent strong financial performance, with Q2 revenue of $243.6 million representing a 55% year-over-year growth, and an upgraded full-year revenue guidance of $980 million to $995 million. The stock's current price of $78.08 is significantly below the average analyst price target of $98, suggesting a potential upside of 25.5%. However, a risk to consider is the high forward P/E ratio of 74.63, indicating that the stock may be overvalued if growth does not continue as expected.

Kiniksa Pharmaceuticals Ltd (KNSA) last closed at $78.08, losing -2.16%. These facts feed the 1-day and 1-week KNSA price prediction above.